London
· Delayed Price · Currency is GBP · Price in USD Madrigal Pharmaceuticals Statistics
Total Valuation
LON:0JXI has a market cap or net worth of GBP 5.80 billion. The enterprise value is 5.11 billion.
| Market Cap | 5.80B |
| Enterprise Value | 5.11B |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.83% |
| Shares Change (QoQ) | +1.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 11.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 10.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.19 |
| EV / Sales | 84.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.79 |
Financial Position
The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.15.
| Current Ratio | 5.98 |
| Quick Ratio | 5.79 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.27 |
| Interest Coverage | -36.19 |
Financial Efficiency
Return on equity (ROE) is -129.76% and return on invested capital (ROIC) is -66.18%.
| Return on Equity (ROE) | -129.76% |
| Return on Assets (ROA) | -52.25% |
| Return on Invested Capital (ROIC) | -66.18% |
| Return on Capital Employed (ROCE) | -61.21% |
| Revenue Per Employee | 152,421 |
| Profits Per Employee | -1.03M |
| Employee Count | 376 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.52% in the last 52 weeks. The beta is -0.76, so LON:0JXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.76 |
| 52-Week Price Change | +48.52% |
| 50-Day Moving Average | 318.30 |
| 200-Day Moving Average | 272.71 |
| Relative Strength Index (RSI) | 57.12 |
| Average Volume (20 Days) | 155 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.66 |
Income Statement
In the last 12 months, LON:0JXI had revenue of GBP 57.31 million and -386.98 million in losses. Loss per share was -18.67.
| Revenue | 57.31M |
| Gross Profit | 55.23M |
| Operating Income | -408.90M |
| Pretax Income | -386.98M |
| Net Income | -386.98M |
| EBITDA | -408.25M |
| EBIT | -408.90M |
| Loss Per Share | -18.67 |
Balance Sheet
The company has 745.08 million in cash and 88.89 million in debt, giving a net cash position of 656.18 million.
| Cash & Cash Equivalents | 745.08M |
| Total Debt | 88.89M |
| Net Cash | 656.18M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 579.84M |
| Book Value Per Share | 26.59 |
| Working Capital | 660.91M |
Cash Flow
In the last 12 months, operating cash flow was -321.58 million and capital expenditures -1.72 million, giving a free cash flow of -323.30 million.
| Operating Cash Flow | -321.58M |
| Capital Expenditures | -1.72M |
| Free Cash Flow | -323.30M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 96.37% |
| Operating Margin | -713.49% |
| Pretax Margin | -675.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0JXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.83% |
| Shareholder Yield | -14.83% |
| Earnings Yield | -6.67% |
| FCF Yield | -5.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0JXI has an Altman Z-Score of 6.58.
| Altman Z-Score | 6.58 |
| Piotroski F-Score | n/a |